RMD News and Press, ResMed Inc. From 04/25/24

2024-04-25 21:38:02 ET ResMed Inc. (RMD) Q3 2024 Earnings Conference Call April 25, 2024, 4:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial O...

2024-04-25 16:30:00 ET More on ResMed ResMed: Not A Sleeper ResMed Q3 2024 Earnings Preview Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down Seeking Alpha’s Quant Rating on ResMed Historical earnings data for ResMed ...

Year-over-year revenue grows 7% , operating profit up 25% , non-GAAP operating profit up 23% Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://...

Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...

2024-04-24 17:20:53 ET More on ResMed ResMed: Not A Sleeper Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down Mizuho sees ResMed as 'overwhelming beneficiary' of Philips consent decree Seeking Alpha’s Quant Rating on ResMed ...

2024-04-17 18:51:53 ET For both the biotech and pharmaceutical industries, what happens in the laboratory is critical to success (or failure, on the flip side). Some good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of the pharmaceutical ...

2024-04-17 10:30:28 ET More on Inspire Medical Systems Inspire Medical Systems: A Potential Example Of Market Mispricing Inspire Medical Systems: Strong Q4 Results But Growth Might Be Slowing Inspire Medical: A Good Night Sleep Baird puts Inspire on top idea ...

2024-04-17 08:21:19 ET Losers: Arrowroot Acquisition Corp ( AILE ) -34% . Hub Cyber Security Ltd ( HUBC ) -22% . Longeveron ( LGVN ) -18% announces exercise of warrants for $6.2 Million gross proceeds . Sage Therapeutics SAGE -19% after mi...

2024-04-17 07:04:07 ET More on Eli Lilly Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets GLP-1s ...

2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...